Divya Raghavan
( out of 95 reviews )

Divya Raghavan, MD

Languages spoken: English

Clinical Locations

Farmington Health Center

Farmington Health Center Nephrology
Farmington
801-213-3200

Boise Specialty Clinic at St. Luke's Meridian Medical Center

Boise Specialty Clinic
Meridian
801-581-2634

Transplant Center

Transplant Center
Salt Lake City
801-581-2634

  • Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Nephrology)

    Patient Rating

    4.8 /5
    ( out of 95 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    January 20, 2025
    UNIVERSITY HOSPITAL

    Dr. Raghavan is an excellent doctor. She is very helpful and explains things thoroughly.

    January 17, 2025
    UNIVERSITY HOSPITAL

    She comes across as being knowledgeable on kidney transplants.

    January 16, 2025
    FARMINGTON HEALTH CENTER

    Outstanding knowledge. Explained the process to me very well. Answer my questions thoroughly .

    December 08, 2024
    UH HOSPITALS AND CLINICS

    A great provider.

    December 08, 2024
    UH HOSPITALS AND CLINICS

    Dr. Raghavan was great, and made me feel like I have a very good team to care for me when i get my transplant.

    November 29, 2024
    UH HOSPITALS AND CLINICS

    She tells it very well what is going to happen. Thanks.

    November 14, 2024
    UH HOSPITALS AND CLINICS

    Claridad en la atención

    November 13, 2024
    UH HOSPITALS AND CLINICS

    She is very caring, she listens to your concerns and acts on them.. she doesn't make you feel like she's in a hurry. She takes her time to address everything..

    November 10, 2024
    UH HOSPITALS AND CLINICS

    Doctor Raghavan is very thorough and she makes me feel very comfortable

    See More Patient Comments

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Associate Professor (Clinical)
    Academic Divisions Nephrology & Hypertension
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Nephrology)

    Education history

    Fellowship Transplant Nephrology - University of Utah School of Medicine Fellow
    Fellowship Nephrology - University of Utah School of Medicine Fellow
    Residency University of Utah School of Medicine Visiting Resident
    Residency Internal Medicine - University of Illinois College of Medicine at Urbana-Champaign Resident
    Internship Kilpauk Medical College Intern
    Professional Medical Medicine - Kilpauk Medical College M.D.

    Selected Publications

    Journal Article

    1. Yamauchi J, Raghavan D, Imlay H, Jweehan D, Oygen S, Marineci S, Remport A, Hall IE, Molnar MZ (2024). Deceased Organ Donor HTLV Screening Practices Postelimination of Universal Screening in the United States. Transplant Direct, 10(10), e1707. (Read full article)
    2. Yamauchi J, Raghavan D, Jweehan D, Oygen S, Marineci S, Hall IE, Molnar MZ (2024). Belatacept Versus Tacrolimus for Kidney Transplant Recipients of Deceased Donors With Acute Kidney Injury: US National Database Study. Transplantation. (Read full article)
    3. Yamauchi J, Raghavan D, Jweehan D, Oygen S, Marineci S, Hall IE, Molnar MZ (2024). Kidney Transplant Outcomes in Amyloidosis: US National Database Study. Transplantation. (Read full article)
    4. Sarwal A, Yamauchi J, Raghavan D, Shihab F, Fornadi K, Rofaiel G, Zimmerman M, Campsen J, Baker N, Akhila Ganireddy Y, Aviles-Ovalle L, Baker T, Hall IE, Molnar MZ (2023). Throwing stones: kidney stone incidence in living kidney donor candidates with increased metabolic risk. Ren Fail, 45(1), 2226763. (Read full article)
    5. Yamauchi J, Raghavan D, Rofaiel G, Zimmerman M, Potluri VS, Baker T, Campsen J, Hall IE, Molnar MZ (2023). Therapeutic Donor Kidney Transplant Outcomes: Comparing Early US Experiences Using Optimal Matching. Transplant Direct, 9(12), e1554. (Read full article)
    6. Yamauchi J, Azhar A, Hall IE, Bhalla A, Potluri VS, Tanriover B, Gupta G, Imlay H, Truax C, Balaraman V, Raghavan D, Zimmerman M, Campsen J, Rofaiel G, Baker T, Molnar MZ (2023). Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clin J Am Soc Nephrol, 18(11), 1466-1475. (Read full article)

    Editorial

    1. Yamauchi J, Hall IE, Raghavan D (2024). Implantation Biopsy in Living-Donor Kidney Transplantation: Expectations, Utility, and Limitations. Am J Kidney Dis. (Read full article)
    2. Raghavan D, Tomacruz IDV, Hall IE (2021). Deceased-Donor Kidneys: Is Past Performance an Indicator of Future Transplant Success? Kidney Int Rep, 6(8), 2025-2027. (Read full article)
    3. Raghavan D, Hall IE (2021). Dialysis and Transplant Access: Kidney Capitalism at a Crossroads? Clin J Am Soc Nephrol, 16(6), 846-847. (Read full article)

    Letter

    1. Molnar MZ, Hall IE, Raghavan D, Shihab F, Imlay H, Hanson KE, Gomez CA, Campsen J, Kim R, Baker N, Rofaiel G (2021). Kidney transplantation from SARS-CoV-2-positive deceased donor. [Letter to the editor]. Am J Transplant, 22(4), 1280-1282. (Read full article)